May 27, 2023 USPTO approves AliquantumRx Inc.’s patent “Salts and Polymorphs of Cethromycin for the Treatment of Bacterial and Protozoan Disease”
AliquantumRx Inc., a Johns Hopkins FastForward company supported by Maryland Technology Development Corporation (TEDCO) is proud to announce the approval of its patent “Salts and Polymorphs of Cethromycin for the Treatment of Bacterial and Protozoan Disease”. “The Maryland Innovation Initiative (MII) is glad to have been a part of AliquantumRx Inc.’s early innovation journey,” said […]